Skip to main content
Caplight Logo









MetaModix

MetaModix

Private
Plymouth, MinnesotaHealthcare & Life Scienceshttp://metamodix.com/

Last Round

VC Round

Jan 26, 2023

Total Funding Raised

$5.24M

Company Overview

MetaModix operates in Healthcare & Life Sciences and is based in Plymouth, Minnesota. Its latest recorded funding round was a VC Round in January 2023.

MetaModix is a biotechnology company that develops nonsurgical, drug-free device therapies for the treatment of metabolic diseases including Type 2 Diabetes, obesity, and NASH.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MetaModix Comparables

Compare MetaModix with similar companies based on industry and business-model similarity.

MetaModix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Keyron Medical Technology
91%
Morphic Medical
88%
BariaTek Medical
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MetaModix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 26, 2023
Series AMar 28, 2017
Series AJun 24, 2015
VC RoundApr 7, 2014
VC RoundMar 28, 2013
Seed
Feb 15, 2012
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 28, 2017

    $1.2M round raised

  • Jun 24, 2015

    Raised $1.75M in Series A funding.

Book a demo to see all signals

For institutional investors. Book with your work email.

MetaModix Filings

Explore SEC and related filing metadata, where available.

MetaModix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MetaModix's valuation, stock price, and market status.

Is MetaModix a public or private company?

MetaModix is a private company.

What is the current stock price of MetaModix?

MetaModix is a private company, so its shares have no public market price. Caplight tracks MetaModix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MetaModix worth (valuation)?

Valuation information for MetaModix is not publicly available.

Can I buy MetaModix stock?

MetaModix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MetaModix's last funding round?

MetaModix's most recent funding round was VC Round on January 26, 2023.

Who are the main investors in MetaModix?

Investor information for MetaModix is not publicly disclosed.

Will MetaModix IPO soon?

No public IPO plans have been announced for MetaModix.

How can I track MetaModix secondary market activity?

Caplight tracks bids, offers, and trades in MetaModix's shares on secondary markets.

Firmographic Details

HeadquartersPlymouth, Minnesota
Employee Range3
Year Founded2009
Last FundingJan 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?